Association of systemic inflammatory markers with clinical adverse prognosis and outcomes in HFpEF: a systematic review and meta-analysis of cohort studies DOI Creative Commons

Zhenyue Fu,

Pengfei Liu,

Xiya Gao

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2024, Номер 11

Опубликована: Сен. 30, 2024

Objective To evaluate the association between systemic inflammatory markers and clinical outcomes (all-cause mortality, cardiovascular rehospitalization) in patients with heart failure preserved ejection fraction (HFpEF). Methods We conducted a comprehensive literature search PubMed, Embase, Ovid Medline databases from inception to June 27, 2024. Studies were included if they observational studies involving HFpEF over 18 years old, exposure reporting on adverse prognosis outcomes. The Newcastle-Ottawa Scale (NOS) was used assess study quality. Results Eight ultimately meta-analysis which involved 9,744 participants six countries. showed that significantly associated all-cause mortality (HR 1.43, 95% CI 1.19–1.72, p < 0.05), 2.04, 1.33–3.12, rehospitalization 2.83, 0.92–8.67, 0.05) patients. Low heterogeneity observed across (I 2 = 0.00%). Sensitivity publication bias analyses indicated results robust. Conclusion Systemic demonstrate significant predictive value for findings suggest monitoring inflammation may provide valuable prognostic information clinicians managing Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=562698 , identifier (CRD42024562698).

Язык: Английский

The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes DOI Creative Commons
Dragoș-Florin Babă, Horaţiu Suciu, Călin Avram

и другие.

Medicina, Год журнала: 2024, Номер 60(11), С. 1801 - 1801

Опубликована: Ноя. 3, 2024

: Cardiac transplantation represents the option for patients with end-stage heart failure (HF), providing best survival rate. However, postoperative complications of transplant remain a challenge clinicians. The objective our study was to evaluate effect preoperative chronic HF treatment on occurrence in-hospital complications.

Язык: Английский

Процитировано

1
Inflammation in heart failure with preserved ejection fraction: A bystander or a participant? DOI
Min Zhong, Xiaomin Yan

International Journal of Cardiology, Год журнала: 2024, Номер 408, С. 132144 - 132144

Опубликована: Май 6, 2024

Язык: Английский

Процитировано

0
Reply to the letter entitled “Inflammation in Heart Failure with Preserved Ejection Fraction: A Bystander or A Participant?” by Zhong M and Yan X DOI
João Pedro Ferreira, Faı̈ez Zannad, Scott D. Solomon

и другие.

International Journal of Cardiology, Год журнала: 2024, Номер 411, С. 132278 - 132278

Опубликована: Июнь 15, 2024

Язык: Английский

Процитировано

0
Association of systemic inflammatory markers with clinical adverse prognosis and outcomes in HFpEF: a systematic review and meta-analysis of cohort studies DOI Creative Commons

Zhenyue Fu,

Pengfei Liu,

Xiya Gao

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2024, Номер 11

Опубликована: Сен. 30, 2024

Objective To evaluate the association between systemic inflammatory markers and clinical outcomes (all-cause mortality, cardiovascular rehospitalization) in patients with heart failure preserved ejection fraction (HFpEF). Methods We conducted a comprehensive literature search PubMed, Embase, Ovid Medline databases from inception to June 27, 2024. Studies were included if they observational studies involving HFpEF over 18 years old, exposure reporting on adverse prognosis outcomes. The Newcastle-Ottawa Scale (NOS) was used assess study quality. Results Eight ultimately meta-analysis which involved 9,744 participants six countries. showed that significantly associated all-cause mortality (HR 1.43, 95% CI 1.19–1.72, p < 0.05), 2.04, 1.33–3.12, rehospitalization 2.83, 0.92–8.67, 0.05) patients. Low heterogeneity observed across (I 2 = 0.00%). Sensitivity publication bias analyses indicated results robust. Conclusion Systemic demonstrate significant predictive value for findings suggest monitoring inflammation may provide valuable prognostic information clinicians managing Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=562698 , identifier (CRD42024562698).

Язык: Английский

Процитировано

0